全球结核病疫苗基金会 Aeras 
 是一家非盈利性产品研发机构，致力于开发有效的结核病疫苗和生物制剂，以可负担和可持续的方式用于各年龄群体结核病的预防。Aeras 运用其广泛的能力和技术与众多合作者及利益相关方共同支持疫苗和其他生物药剂的开发，以解决资源缺乏人群在结核病及其他重大公共健康问题方面的需求。Aeras 至今已发明或支持了6种结核病候选疫苗的开发，其中5种正在非洲、亚洲和北美进行 I 期和 II 期临床实验。Aeras 获得了比尔与美琳达-盖茨基金会 (Bill & Melinda Gates Foundation)、其他私人基金和多个政府部门的资助。该公司总部设在美国马里兰州 Rockville，拥有先进的生产和实验设施，在南非的开普敦设有分部。

Aeras is a non-profit product development organization dedicated to the development of effective tuberculosis (TB) vaccines and biologics to prevent TB across all age groups in an affordable and sustainable manner. Aeras utilizes its broad capabilities and technologies in collaboration with numerous partners and stakeholders to support the development of vaccines and other biopharmaceuticals to address TB and other significant public health needs of underserved populations.

In the pursuit of our Mission, we are guided by our Core Values. These Core Values express our aspirations and the behaviors we want to exhibit and model. They shape the culture and character of Aeras and inform all of our decisions and actions.

Excellence: We are committed to high-quality results that make a positive impact in keeping with our Mission.

Leadership: We promote an environment that fosters empowerment, taking initiative and leading by example.

Collaboration: We value teamwork, knowledge sharing and working in partnerships—internal and external—to achieve common goals.

Respect: We recognize the dignity of each individual and value the contributions, opinions and expertise of all members of our organization and larger community.

Integrity: We maintain the highest ethical standards and transparency in our work and in our dealings with partners, stakeholders and our fellow employees.